Zobrazeno 1 - 10
of 59
pro vyhledávání: '"J Skoupá"'
Autor:
J Skoupá
Publikováno v:
Value in Health Regional Issues. 13:55-58
The legal background of the current pharmaceutical pricing and reimbursement (PR) setting in the Czech Republic is based on Act 48/1997. Since 2008, the PR process has been coordinated by the State Institute for Drug Control, which is the main stakeh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dbb0d7819c6f18e193d1b80599fa1ba
https://doi.org/10.1016/j.vhri.2017.08.002
https://doi.org/10.1016/j.vhri.2017.08.002
Publikováno v:
Value in health regional issues. 4
Objectives To compare data requirements and their availability for health economic (HE) evaluations in five countries in Central/Eastern Europe (CEE) (Poland, the Czech Republic, Slovakia, Hungary, and Romania) and five countries in Western Europe (W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a114298ccd9d0e0aa1110a74676f03e8
https://pubmed.ncbi.nlm.nih.gov/29702807
https://pubmed.ncbi.nlm.nih.gov/29702807
Publikováno v:
Value in health regional issues. 16
Background Chronic obstructive pulmonary disease (COPD) represents an illness with significant healthcare and societal impacts. Fixed combinations of long-acting beta-agonists (LABA) and inhaled corticosteroids have been used for COPD treatment as th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d278efd890d72c92c2522f5748214bf3
https://pubmed.ncbi.nlm.nih.gov/30539739
https://pubmed.ncbi.nlm.nih.gov/30539739
Publikováno v:
Journal of Medical Economics. 16:1089-1095
The Czech Republic is faced with making choices between pharmaceutical products, including depot injectable antipsychotics. A pharmacoeconomic analysis was conducted to determine the cost-effectiveness of atypical depots.An existing 1-year decision-a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d891a9217c6a8d765d132f83c4cfe84
https://doi.org/10.3111/13696998.2013.820193
https://doi.org/10.3111/13696998.2013.820193
Autor:
Yaroslav Winter, Jens P. Reese, Kai Bötzel, Wolfgang H. Oertel, Karla Eggert, J Skoupá, Evzen Ruzicka, Hana Brozova, Richard Dodel, Sonja von Campenhausen
Publikováno v:
Parkinsonism & Related Disorders. 16:51-56
Life expectancy is increasing worldwide and the burden of Parkinson's disease (PD) is growing. There are several cost-of-illness studies for PD from Western Europe and the USA, however, data about the costs associated with PD in Eastern Europe are st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bb5501a04e1dccda019117ca2747d0d
https://doi.org/10.1016/j.parkreldis.2009.07.005
https://doi.org/10.1016/j.parkreldis.2009.07.005
Publikováno v:
Value in Health. 16(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::776334585863e644d1b153f51b3abe20
Publikováno v:
Value in Health. 16(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd314c0249cfa8c766a4ef553ae6e952
Publikováno v:
Scandinavian journal of urology. 48(1)
The aim of this study was to evaluate the persistence of first line anticholinergic medication use by patients with overactive bladder (OAB). Data from a hospital outpatient database were matched with information obtained by a telephone survey of pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7066dcbcae30299236879736ca60f073
https://pubmed.ncbi.nlm.nih.gov/23870042
https://pubmed.ncbi.nlm.nih.gov/23870042
Publikováno v:
Value in Health. 14(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6eb0cf7e6e070fb261125fab64b54b1
Autor:
Richard Dodel, Kai Bötzel, Wolfgang H. Oertel, Uwe Siebert, Karin Berger, Paolo Barone, Alla Guekht, Yaroslav Winter, Monika Balzer-Geldsetzer, Céu Mateus, J Skoupá, Evzen Ruzicka, Karl P. Pfeiffer, Sabine Geiger-Gritsch, Antonio M. Rodrigues e Silva, Sonja von Campenhausen, Jens P. Reese, Christina Sampaio, Werner Poewe
Publikováno v:
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 21(2)
We investigated the costs of Parkinson's Disease (PD) in 486 patients based on a survey conducted in six countries. Economic data were collected over a 6-month period and presented from the societal perspective. The total mean costs per patient range
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fa6c26b1b5d89762ba4a0f230c0da15
https://pubmed.ncbi.nlm.nih.gov/21109406
https://pubmed.ncbi.nlm.nih.gov/21109406